Join
Live feed
·
INSIDERFilingvia Quantisnow
Roivant Sciences Ltd. logo

President & Immunovant CEO Venker Eric sold $7,324,000 worth of shares (200,000 units at $36.62) as part of a pre-agreed trading plan and exercised 200,000 shares at a strike of $3.85 (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ROIV· Roivant Sciences Ltd.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ROIV (Roivant Sciences Ltd.) and more on Quantisnow.

President & Immunovant CEO Venker Eric sold $7,324,000 worth of shares (200,000 units at $36.62) as part of a pre-agreed trading plan and exercised 200,000 shares at a strike of $3.85 (SEC Form 4) | Quantisnow